Want to see CVSA full AI Analyst Report?
CVSA Stock Chart & Stats
$115.84
$3.59(3.10%)
At close: 4:00 PM EDT
$115.84
$3.59(3.10%)
Day’s Range― - ―
52-Week Range$86.97 - $156.26
Previous CloseN/A
Volume76.09K
Average Volume (3M)367.02K
Market Cap
$4.09B
Enterprise Value$4.60K
Total Cash (Recent Filing)$148.84M
Total Debt (Recent Filing)$736.29M
Price to Earnings (P/E)18.0
Beta0.64
Next Earnings
Aug 06, 2026EPS Estimate
1.89Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)7.02
Shares Outstanding34,030,888
10 Day Avg. Volume376,642
30 Day Avg. Volume367,016
Financial Highlights & Ratios
PEG Ratio0.25
Price to Book (P/B)3.29
Price to Sales (P/S)2.64
P/FCF Ratio16.41
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$172.50Price Target Upside48.91% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)8.89
Revenue Forecast (FY)$2.07B
Bulls Say, Bears Say
Bulls Say
Sustainable Profitability & MarginsConsistently strong gross and operating margins indicate durable pricing power and efficient delivery in Covista's education model. High EBITDA margins support reinvestment, debt servicing and shareholder actions, and provide a buffer against cyclical revenue swings over the next several quarters.
Enrollment Momentum & ScaleSustained enrollment growth across programs (Walden, Chamberlain, Med/Vet) strengthens recurring revenue and expands scale benefits. A larger student base boosts lifetime revenue, supports campus expansion and credential rollouts, and underpins long‑term margin stability and competitive positioning.
Improving Balance Sheet & Cash GenerationStronger FCF and lower net leverage enhance financial flexibility for strategic investments, buybacks and debt servicing. The refinancing reduces interest cost and extends maturities, materially improving covenants and optionality and lowering refinancing risk over the medium term.
Bears Say
Free Cash Flow VolatilityIntermittent and declining FCF growth undermines the predictability of internal funding for capex, campus builds and buybacks. Historic swings (including weak/negative FCF in 2022) raise execution and liquidity risk if enrollment or margins soften, necessitating external financing options.
Meaningful Absolute Debt LoadAlthough leverage has improved, a sizable absolute debt stock increases sensitivity to slower cash generation or rising rates. Debt service and covenant maintenance could constrain capital allocation and amplify downside in a downturn, limiting nimbleness for M&A or larger program investments.
Investment & Execution HeadwindsA planned ramp in strategic spending and capex to fund campuses and programs will weigh near-term margins and cash flow. Modest recovery at Chamberlain and weaker RN‑to‑BSN demand create execution risk that could delay payback on those investments and pressure profitability through the next several quarters.
Covista News
CVSA FAQ
What was Covista Inc.’s price range in the past 12 months?
Covista Inc. lowest stock price was $86.97 and its highest was $156.26 in the past 12 months.
What is Covista Inc.’s market cap?
Covista Inc.’s market cap is $4.09B.
When is Covista Inc.’s upcoming earnings report date?
Covista Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 7 days.
How were Covista Inc.’s earnings last quarter?
Covista Inc. released its earnings results on May 07, 2026. The company reported $1.98 earnings per share for the quarter, beating the consensus estimate of $1.722 by $0.258.
Is Covista Inc. overvalued?
According to Wall Street analysts Covista Inc.’s price is currently Undervalued.
Does Covista Inc. pay dividends?
Covista Inc. pays a Semiannually dividend of $0.18 which represents an annual dividend yield of N/A. See more information on Covista Inc. dividends here
What is Covista Inc.’s EPS estimate?
Covista Inc.’s EPS estimate is 1.89.
How many shares outstanding does Covista Inc. have?
Covista Inc. has 34,030,888 shares outstanding.
What happened to Covista Inc.’s price movement after its last earnings report?
Covista Inc. reported an EPS of $1.98 in its last earnings report, beating expectations of $1.722. Following the earnings report the stock price went up 14.299%.
Which hedge fund is a major shareholder of Covista Inc.?
Currently, no hedge funds are holding shares in CVSA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Covista Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$172.50 (48.91% Upside)
$172.50 (48.91% Upside)
Blogger Sentiment
Bullish
CVSA Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 51.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.3%
Last 30 Days ▲ 10.2%
Last 30 Days ▲ 10.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.43%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-1.88%
Trailing 12-Months
Company Description
Covista Inc.
Adtalem Global Education, Inc. is an enterprise dedicated to providing higher education. The company organizes its operations into three primary divisions: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment delivers various degree and non-degree offerings within the nursing and broader health professions higher education sector. Through its Walden segment, the company offers extensive online learning options, including certificates, bachelor's, master's, and doctoral degrees in a wide range of subjects such as nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. The Medical and Veterinary division provides both degree-granting and non-degree curricula tailored for post-secondary education in medicine and veterinary sciences. Dennis J. Keller and Ronald L. Taylor established the company in 1973, and its corporate headquarters are situated in Chicago, Illinois.
CVSA Company Deck
CVSA Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: enrollment growth across institutions, improved margins (when adjusting for a one-week timing shift), raised revenue and EPS guidance, robust free cash flow, balance sheet improvement, share repurchases, campus expansion plans, and technology/AI initiatives. Near-term headwinds include an $18M timing impact at Walden that masked stronger underlying results, modest absolute enrollment improvement at Chamberlain this quarter (0.5%), continued investment-driven CapEx and strategic spending, and an expected higher effective tax rate. Overall, the positives (organic growth, margin expansion excluding timing, raised guidance, cash generation, and clear remediation at Chamberlain) outweigh the transitory and execution-related challenges noted.View all CVSA earnings summariesCVSA Stock 12 Month Forecast
Average Price Target
$172.50
▲(48.91% Upside)
Technical Analysis
Perdoceo Education
―
Grand Canyon Education
―
Strategic Education
―
Graham Holdings
―
Laureate Education
―
Ownership Overview
2.72% Insiders
40.56% Mutual Funds
0.66% Other Institutional Investors
27.76% Public Companies and
Individual Investors